Aeropay | $20,000,000 | (May 17, 2024)
Bedrock Materials | $9,000,000 | (May 17, 2024)
OTPLESS | $3,500,000 | (May 17, 2024)
Certified by Founder
Lodge
Latigo Biotherapeutics, Inc.
start up
United States
- Thousand Oaks, CA
- 15/02/2024
- Series A
- $135,000,000
Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a privately held clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction. The company’s proprietary, in-house technology generates novel drugs against targets validated by human genetics using the most advanced artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to optimize potency and selectivity. The company is backed by top-tier investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.
- Industry Biotechnology Research
- Website https://latigobio.com/
- LinkedIn https://www.linkedin.com/company/latigobio/
ekko | $2,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
HEPHAISTOS-Pharma | $11,189,199 | (May 17, 2024)
Keyper | $4,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
Angel AI | $4,750,000 | (May 17, 2024)
InstaAstro | $2,300,000 | (May 17, 2024)
Fay | $25,000,000 | (May 16, 2024)